Go Pro

Nykredit A S Makes New $23.70 Million Investment in Astera Labs, Inc. $ALAB

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Nykredit A S bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 49,064 shares of the company's stock, valued at approximately $23,699,000.

Several other hedge funds have also modified their holdings of the stock. Keating Financial Advisory Services Inc. bought a new position in Astera Labs in the 2nd quarter worth approximately $25,000. Archer Investment Corp acquired a new position in Astera Labs during the 2nd quarter worth $30,000. Transamerica Financial Advisors LLC bought a new position in Astera Labs in the 2nd quarter valued at $35,000. Johnson Financial Group Inc. acquired a new stake in shares of Astera Labs in the 2nd quarter valued at $43,000. Finally, Bell Investment Advisors Inc acquired a new stake in shares of Astera Labs in the 2nd quarter valued at $43,000. 60.47% of the stock is owned by institutional investors.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for robust third-quarter growth and reinforcing the company’s AI data-center expansion story. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
  • Positive Sentiment: Astera’s role in supplying high-speed connectivity for large-scale AI data centers remains a key investment attraction, although NVIDIA retains a broader competitive advantage through its chips and software ecosystem. Better Artificial Intelligence Stock: Astera Labs vs. NVIDIA
  • Neutral Sentiment: The stock remains under pressure following its latest earnings report, declining 13.9% since results were released and 24% over the past month. The decline highlights elevated expectations and uncertainty about the next phase of growth. Why Is Astera Labs, Inc. (ALAB) Down 13.9% Since Last Earnings Report?
  • Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his position by 41.9%. Director Stefan Dyckerhoff also sold a combined 12,499 shares worth about $3.4 million. Both transactions were conducted under pre-arranged Rule 10b5-1 trading plans, which may lessen their signal as discretionary insider bearishness but could still weigh on sentiment and add selling supply. SEC Form 4 Filing

Astera Labs Trading Up 3.2%

Shares of ALAB opened at $282.82 on Friday. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock has a market cap of $49.07 billion, a P/E ratio of 140.01 and a beta of 3.77. The stock's 50-day moving average price is $332.37 and its two-hundred day moving average price is $253.97.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company's revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Ratings Changes

ALAB has been the subject of a number of recent research reports. Stifel Nicolaus boosted their target price on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research report on Wednesday, June 24th. Zacks Research upgraded Astera Labs from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. UBS Group reissued a "neutral" rating and set a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 5th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Astera Labs in a research note on Tuesday, August 18th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $348.33.

Check Out Our Latest Research Report on Astera Labs

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the sale, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This trade represents a 69.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 592,244 shares of company stock worth $209,729,973 over the last ninety days. 10.40% of the stock is owned by corporate insiders.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines